BioTechnology: An Indian Journal
ISSN (PRINT): 0974-7435

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Ventricular Hypertrophy Impact Factor

Left ventricular hypertrophy (LVH) is an autonomous hazard factor and indicator of cardiovascular (CV) occasions and all-cause mortality. Patients with LVH are at expanded hazard for stroke, congestive cardiovascular breakdown, coronary illness, and unexpected heart passing. Left ventricular hypertrophy speaks to both an appearance of the impacts of hypertension and other CV chance components after some time just as an inborn condition causing pathologic changes in the CV structure and capacity. We survey the hazard factors for LVH and its outcomes, concentric rebuilding, and its prognostic centrality, clinical advantages and supporting proof for LVH relapse, and its suggestions for the executives. We close our survey summing up the different pharmacological and nonpharmacological remedial choices affirmed for the treatment of hypertension and LVH relapse and the supporting clinical preliminary information for these restorative procedures. Human and animal studies have demonstrated that oxidative stress is among the key factors contributing to cardiac hypertrophy    

High Impact List of Articles

Relevant Topics in General Science

Awards Nomination

Table of Contents

Google Scholar citation report
Citations : 875

BioTechnology: An Indian Journal received 875 citations as per Google Scholar report

Citation image

Indexed In

  • CASS
  • Google Scholar
  • Open J Gate
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Cosmos IF
  • Directory of Research Journal Indexing (DRJI)
  • Secret Search Engine Labs
  • Euro Pub
  • ICMJE

View More

For Authors

For Librarians

Flyer

Open Access Journals